Organic Process Research & Development
ARTICLE
solution of potassium carbonate (180 mL, 6 mL/g) was charged
maintaining the temperature at 50 °C. The mixture was stirred
vigorously at 50 °C for 6 h. The two solution phases were allowed
to settle and were separated at 50 °C. The organic phase was
washed with water (120 mL, 4 mL/g) at 50 °C. The phases were
separated at 50 °C, and the toluene volume was reduced to
120 mL (4 mL/g) by distillation under reduced pressure. The
temperature was adjusted to 60 °C and then cooled to 40 °C over
1 h. The batch was held at 40 °C and then seeded with 2 (150 mg).
The mixture was granulated for 90 min at 40 °C and then cooled
to 20 °C over 4 h. The batch was granulated at 20 °C for 4 h. The
slurry was then cooled to 2 °C over 2 h and granulated at 2 °C for
4 h. The suspension was filtered, the cake was washed with cold
toluene (30 mL, 1 mL/g), and the resulting white solid was dried
at 35 °C for 12 h to give (R)-2-[3-(diisopropylamino)-1-phenyl-
propyl]-4-(hydroxymethyl)phenol 2 (16.43 g) in 85.9% yield. 1H
NMR (400 MHz, DMSO-d6) δ ppm 9.19 (br. s., 1 H); 7.21À
7.32 (m, 4 H); 7.17 (d, J = 1.95 Hz, 1 H); 7.09À7.15 (m, 1 H);
6.94 (dd, J = 8.11, 2.05 Hz, 1 H); 6.72 (d, J = 8.21 Hz, 1 H); 4.93
(br. s., 1 H); 4.32À4.41 (m, 3 H); 2.95 (dt, J = 13.09, 6.55 Hz, 2 H);
2.27À2.37 (m, 2 H); 2.06 (q, J = 7.23 Hz, 2 H); 0.89 (dd, J = 6.45,
1.37 Hz, 12 H). 13C NMR (400 MHz, DMSO-d6) δ ppm 153.4,
145.3, 132.7, 130.8, 128.1, 127.9, 127.6, 126.1, 125.7, 125.5, 125.2,
114.6, 63.0, 47.8, 43.0, 40.6, 36.1, 20.7, 20.5. IR (KBr pellets) cmÀ1
3142, 3082, 3025, 2975, 2936, 2868, 1610, 1491, 1452, 1438, 1388,
1366, 1269, 1242, 1110, 1011, 904, 767, 744, 698. HRMS (ES)
Calcd for C22H32NO2 (MH+) 342.2428, found 342.2435.
(R)-(+)-Isobutyric Acid 2-[3-(Diisopropylamino)-1-phenyl-
propyl]-4-(hydroxymethyl)phenyl Ester 1. (R)-2-[3-(Diisopro-
pylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol 2 (50 g,
0.146 mol, 1.0 equiv) was dissolved in dichloromethane (400 mL,
8 mL/g) and then cooled to À12 °C. To this was added a
solution of isobutyryl chloride (16.15 g, 0.155 mol, 1.04 equiv) in
dichloromethane (250 mL, 5 mL/g), maintaining the reaction
temperature between À15 and À10 °C, followed by a vessel and
line rinse of dichloromethane (100 mL, 2 mL/g). The reaction
mixture was stirred at À12 °C for 2 h. A 5 wt %/wt aqueous
sodium carbonate solution (110 mL, 2.2 mL/g) was then added
to the reaction, allowing the temperature to rise towards 0 °C
during the addition, and the resulting pH was confirmed to be
between pH 7.5 and 8.5. The two phases were allowed to settle,
and the organic phase was sequentially washed with water
(450 mL, 9 mL/g), 5% wt/wt aqueous sodium carbonate
solution (450 mL, 9 mL/g), and twice with water (2 Â
450 mL, 2 Â 9 mL/g). The product solution was then concen-
trated under reduced pressure to a volume of 260 mL, and methyl
ethyl ketone (500 mL, 10 mL/g) was added. The solution was
reconcentrated under reduced pressure to a volume of 260 mL.
Two further additions of methyl ethyl ketone (each of 500 mL,
10 mL/g), each followed by a distillation under reduced pressure
to 260 mL, were performed to remove the dichloromethane. This
provided a methyl ethyl ketone solution of the product (R)-
(+)-isobutyric acid 2-[3-(diisopropylamino)-1-phenylpropyl]-
4-(hydroxymethyl)phenyl ester 1 for use in the next step
(fumarate salt formation). Quantitative HPLC analysis indicated
the solution contained 52.85 g of product (88% yield).
0.131 mol, 1.0 equiv) in methyl ethyl ketone (270 mL, 5 mL/g)
was then added to the slurry of fumaric acid followed by a vessel
and line rinse with methyl ethyl ketone (38 mL, 0.7 mL/g). The
resulting mixture was warmed to 37 °C with agitation for 30 min
ensuring that all the solids fully dissolved. The solution was
filtered into a crystallising vessel, rinsing the vessel and lines with
methyl ethyl ketone (70 mL, 1.3 mL/g). The solution was cooled
to 20 °C and seeded with 1-fumarate (0.54 g). After holding the
mixture at 20 °C for 1 h the slurry was cooled to 5 °C, and filtered
cyclohexane (65 mL, 1.2 mL/g) was added over 1 h. The mixture
was stirred at 5 °C for 8 h and then filtered, washing the cake with
a mixture of cyclohexane (65 mL) and methyl ethyl ketone
(16 mL), followed by cyclohexane (54 mL), and the product was
dried under vacuum at 22 °C for 16 h to give (R)-(+)-isobutyric
acid 2-[3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)-
phenyl ester hydrogen fumarate 1-fumarate (57.1 g, 82% yield).
1H NMR (400 MHz, DMSO-d6) δ ppm 7.71 (br. s., 1 H); 7.26
(m, 4 H); 7.17 (d, J = 8.3 Hz, 1 H); 7.15 (m, 1 H); 6.91 (d, J =
8.3 Hz, 1 H); 6.87 (s, 2 H); 4.84 (br. s., 1 H); 4.62 (d, J = 13.3
Hz, 2 H); 3.96 (t, J = 8.4 Hz, 1 H); 3.63 (sept, J = 6.6 Hz, 2 H);
2.96 (br. s., 1 H); 2.81 (sept, J = 7.0 Hz, 1 H); 2.73 (br. s., 1 H);
2.86À2.57 (m, 4 H); 1.33 (d, J = 7.0 Hz, 6 H); 1.27 (d, J = 6.6
Hz, 12 H). 13C NMR (400 MHz, DMSO-d6) δ ppm 175.6,
170.3, 147.5, 142.3, 140.5, 135.6, 134.4, 128.7, 127.6, 126.8,
126.7, 126.4, 122.2, 63.7, 54.4, 45.8, 41.9, 34.1, 31.6, 19.1, 18.9,
17.7. Anal. Calcd: C (68.29%), H (7.83%), N (2.65%). Found:
C (68.40%), H (7.92%), N (2.58%). IR (KBr pellets) cmÀ1
3473, 2978, 2937, 2877, 2825, 2769, 2696, 1755, 1707, 1570,
1468, 1387, 1234, 1178, 1097, 984, 912, 868, 795, 748, 702.
Mp 103.5 °C.
’ AUTHOR INFORMATION
Corresponding Author
*E-mail: Dirat_olivier@yahoo.co.uk.
’ ACKNOWLEDGMENT
The authors thank Simon Davies, Paul McDaid and Pat
O’Neill from the Pfizer Process Development Center in
Loughbeg (Ireland) for early development work on the
preparation of the lactol; Ciaran Byrne, Mairead Kelleher,
Dennis Lynch, Will Mullally, Sandra Mullane from the Pfizer
API manufacturing plant in Ringaskiddy (Ireland) for running
this process at commercial scale; Robert Bright and Andrew
Fowler from the Sandwich Pilot Plant for scaling-up this
process; Sophie Apoux, Francois Lestremeau and Maura
Wood for help with elucidation of structures; John Deering
and Trevor Newbury for technical assistance with hydrogena-
tion reactions; Charles Gordon and Wilfried Hoffmann for
engineering assessment; Neal Sach and Katie Wilford for
reaction and solubility screening; Christian Regius for process
safety evaluation; Lynsey Hesmondhalgh and Rosalind Sankey
for work on the final steps of the process; Kathryn Arthur,
Steve Belsey, Samantha Johnson, Tony Stevens and Sophie
Vernay for analytical support and Julian Smith for reviewing
and improving this manuscript.
(R)-(+)-Isobutyric Acid 2-[3-(Diisopropylamino)-1-phenyl-
propyl]-4-(hydroxymethyl)phenyl Ester Hydrogen Fuma-
rate 1-Fumarate. Fumaric acid (14.47 g, 0.125 mol, 0.95 equiv)
was slurried in methyl ethyl ketone (162 mL, 3 mL/g) at 20 °C. A
solution of (R)-(+)-isobutyric acid 2-[3-(diisopropylamino)-
1-phenylpropyl]-4-(hydroxymethyl)phenyl ester 1 (54.03 g,
’ REFERENCES
(1) McKeage, K.; Keating, G. M. Drugs 2009, 69 (6), 731.
(2) Malhotra, B.; Gandelman, K.; Sachse, R.; Wood, N.; Michel,
M. C. Curr. Med. Chem. 2009, 16, 4481.
1016
dx.doi.org/10.1021/op200107g |Org. Process Res. Dev. 2011, 15, 1010–1017